Your search for dabigatran returned 51 results

Forty-eight percent of atrial fibrillation (AF) patients, who are at the highest risk of stroke, were not prescribed oral anticoagulant (OAC) medication.

End-stage renal disease patients on dialysis with atrial fibrillation are at high risk for thrombotic complications.

The new findings were based on data from a pooled analysis of two large U.S. commercial health insurance databases.

This marks the fourth FDA approval for the anticoagulant.

According to the findings of a recent study, attorney advertisements appear to influence patients’ decisions on modifying or discontinuing their direct oral anticoagulant (DOAC) medication prior to seeking medical advice.

To identify medications with potential proarrhythmic association.

A study published in JAMA reports that anticoagulants, antibiotics, diabetes drugs, and opioids are the most common drug classes related to emergency department visits for adverse drug events in the country.

The main outcomes and measures were intraocular bleeding events and associated risk ratio for NOACs, compared with warfarin.

A list of medications routinely prescribed in primary care practice that should be used cautiously or avoided in patients with chronic kidney disease (CKD) was compiled in a recently published study in the Annals of Pharmacotherapy.

According to the authors, this is the first study to identify medications most commonly reported for a specific adverse reaction using this database.